W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Financial Figures/Balance Sheet
2007 targets exceeded once again: 15.8% growth in sales and 16.5% pre-tax sales yield

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- annual report 14.03.2008 The stock-listed medical device technology manufacturer WORLD OF MEDICINE achieved a 15.8% growth in sales to TE35,746 for fiscal year 2007. Its pre-tax sales yield equaled 16.5%. In October 2007, the Management Board projected an increase in sales of at least 10% to more than E34 million, and a pre-tax sales yield of at least 13.0%. Strategically significant product launches contributed to the favorable business performance. In addition, one-time earnings from the sale of former subsidiary, IB Laser AG, added E1.1 million before taxes. | |2007 |2006 Change | |Sales |TE35,746 |TE30,859 |+ 15.8% | |EBT |TE5,892 |TE2,678 |+TE3,214 | |Pre-tax sales yield|16.5 % |8.7 % |> 100% | |Earnings per share |E0.80 |E0.29 |> 100% | A pre-tax sales yield of 11% is projected for 2008, and an increase in sales of 7%. The Management Board, however, may pursue further investment in future- oriented projects. If necessary, it will also accept a temporary reduction of the sales yield in order to accomplish these future goals. Today at 10.30 a.m. CET, WORLD OF MEDICINE invites you to a telephone conference on the annual figures for 2007 (Financial Statements Press Conference). Please direct your registration for this event to the Company at stefanie.gehrke@womcorp.com. The Group Annual Financial Report with the full Consolidated Financial Statements for fiscal year 2007 will become available to the public on March 20th at the following link www.world-of- medicine.com/2007/annualfinancialreport/index.htm. The Management Board end of announcement euro adhoc -------------------------------------------------------------------------------- ots Originaltext: W.O.M. World of Medicine AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Stefanie Gehrke, IR/PR, Fon +49 (0) 30 399 81 566, Fax: +49 (0) 30 399 81 641, E-mail: stefanie.gehrke@womcorp.com Branche: Pharmaceuticals ISIN: DE0006637390 WKN: 663739 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse München / free trade

Das könnte Sie auch interessieren: